EDGAR Filing Documents for 0001213900-21-008254

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:

SEC Accession No. 0001213900-21-008254

Filing Date

2021-02-11

Accepted

2021-02-11 06:18:00

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	ea135116-8k_cmlifesciences.htm	DEFA14A	80105
2	AGREEMENT AND PLAN OF MERGER, DATED AS OF FEBRUARY 9, 2021, BY AND AMONG, CM LIF	ea135116ex2-1_cmlife.htm	EX-2.1	798100
3	FORM OF SUBSCRIPTION AGREEMENT	ea135116ex10-1_cmlife.htm	EX-10.1	239598
4	FORM OF SHAREHOLDER LOCK-UP AGREEMENT	ea135116ex10-2_cmlife.htm	EX-10.2	27243
5	SPONSOR SUPPORT AGREEMENT, DATED AS OF FEBRUARY 9, 2021, BY AND AMONG CMLS HOLDI	ea135116ex10-3_cmlife.htm	EX-10.3	58956
6	FORFEITURE AGREEMENT, DATED AS OF FEBRUARY 9, 2021, BY AND BETWEEN CMLS HOLDINGS	ea135116ex10-4_cmlife.htm	EX-10.4	24495
7	FORM OF AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT	ea135116ex10-5_cmlife.htm	EX-10.5	199149
	Complete submission text file	0001213900-21-008254.txt		1428645

Mailing Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10020

Business Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10020 212 474 6700

CM Life Sciences, Inc. (Filer) CIK: 0001818331 (see all company filings)